You are viewing a free limited preview of Global Blood Therapeutics
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
Global Blood Therapeutics is a privately held company that is focused on building a pipeline of oral medicines to revolutionize the treatment of chronic blood-based diseases and severe genetic disorders for which there are currently no cures available and only extremely limited therapeutic options. Global Blood Therapeutics was formed by its $40.7 million venture investment from Third Rock Ventures.
| Company Tags: | VC Backed |
| Fiscal Year End: | 12/31 |
| City: | San Francisco |
| State/Province: | California |
| Country: | United States |
| Website: | www.globalbloodtx.com |
| Founders: | Andrej Sali David Phillips Jack Taunton Matthew Jacobson |
| Healthcare > Pharmaceuticals |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All Global Blood Therapeutics Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Employee Figures | 2012 |
| Total Employees | View |
| Financial Notes: | |
| * | Global Blood Therapeutics fiscal year end: 12/31 |
Export All Global Blood Therapeutics Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Jun. 2012 | View | A | Venture Capital | |
| Details | Total Round A View | |||
| Total of Funding Shown Above View | ||||
Missing a deal? Tell us about it! tips@privco.com
|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,160 |
| Private Investors | 12,020 |
| Private M&A Deals | 43,175 |
| VC/Funding Rounds | 36,101 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of Global Blood Therapeutics
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report